Thyroid dysfunction in women with systemic sclerosis

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 305-311

  Marasini, Bianca ^a   Ferrari, Pier Alda ^a   Solaro, Nadia ^b   Selmi, Carlo ^c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypothyroidism; Scleroderma; Thyroid autoantibodies

Indexed keywords

LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; RISK ASSESSMENT; SCREENING TEST; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS; THYROID DISEASE; THYROID FUNCTION TEST;

EID: 34948822277     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.032     Document Type: Conference Paper

References (31)

1. ARNAOUT, M.A., N.S. NASRALLAH & M. S. EL-KHATEEB. 1994. Prevalence of abnormal thyroid function tests in connective tissue disease. Scand. J. Rheumatol. 23: 128-132.
2. KAHL, L.E., T.A. MEDSGER JR., & I. KLEIN. 1986. Prospective evaluation of thyroid function in patients with systemic sclerosis (scleroderma). J. Rheumatol. 13: 103-107.
3. DE KEYSER, L. et al. 1990. Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J. Endocrinol. Invest. 13: 161-169.
4. LINCOLN, S.R., R.W. KE & W.H. KUTTEH. 1999. Screening for hypothyroidism in infertile women. J. Reprod. Med. 44: 455-457.
5. ALLAN, W.C. et al. 2000. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J. Med. Screen. 7: 127-130.
6. KANAYA, A.M. et al. 2002. Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch. Intern. Med. 162: 773-779.
7. SURKS, M.I. et al. 2004. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291: 228-238.
8. AGUGLIA, G. et al. 2001. Left ventricular diastolic function in systemic sclerosis. J. Rheumatol. 28: 1563-1567.
9. BIONDI, B. et al. 1999. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 84: 2064-2067.
10. BIONDI, B. et al. 2002. Effects of subclinical thyroid dysfunction on the heart. Ann. Intern. Med. 137: 904-914.
11. VANDERPUMP, M.P. et al. 1995. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 43: 55-68.
12. HUBER, G. et al. 2002. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J. Clin. Endocrinol. Metab. 87: 3221-3226.
13. HELFAND, M. 2004. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 140: 128-141.
14. . 1980. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 23: 581-590.
15. CHAISSON, C.E. et al. 1996. Lack of association between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study. J. Rheumatol. 23: 711-715.
16. MOURIER-CLAVREUL, M.C., H. ROUSSET & A. CLAUDY. 1989. Scleroderma and thyroid diseases. Ann. Dermatol. Venereol. 116: 701-706.
17. GHAYAD, E. et al. 1997. Scleroderma with anomalies of the thyroid function. 7 cases. Ann. Med. Intern. (Paris) 148: 307-310.
18. U.S. PREVENTIVE SERVICES TASK FORCE. 2004. Screening for thyroid disease: recommendation statement. Ann. Intern. Med. 140: 125-127.
19. COOPER, D.S. 2004. Thyroid disease in the oldest old: the exception to the rule. JAMA 292: 2651-2654.
20. KAHALY, G.J. 2000. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10: 665-679.
21. MOLNAR, I. et al. 1992. Evaluation of thyroid function and anti-thyroid autoantibodies in systemic sclerosis. Acta. Derm. Venereol. 72: 112-114.
22. MOLTENI, M. et al. 1997. Anti-thyroid antibodies in Italian scleroderma patients: association of anti-thyroid peroxidase (anti-TPO) antibodies with HLA-DR15. Clin. Exp. Rheumatol. 15: 529-534.
23. INNOCENCIO, R.M., J.H. ROMALDINI & L.S. WARD. 2003. High prevalence of thyroid autoantibodies in systemic sclerosis and rheumatoid arthritis but not in the antiphospholipid syndrome. Clin. Rheumatol. 22: 494.
24. ZOPHEL, K. et al. 2003. Autoantibodies to thyroperoxidase (TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clin. Lab. 49: 591-600.
25. LUBOSHITZKY, R. et al. 2002. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12: 421-425.
26. RUSSELL, M.E. et al. 1996. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J. Clin. Invest. 97: 833-838.
27. TOMER, Y. et al. 2001. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab. 86: 1687-1693.
28. . 1998. Clinical guideline, part 1. Screening for thyroid disease. American College of Physicians. Ann. Intern. Med. 129: 141-143.
29. LADENSON, P.W. et al. 2000. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch. Intern. Med. 160: 1573-1575.
30. HAMANO, K. & M. INOUE. 2005. Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr. J. 52: 95-101.
31. CHU, J.W. & L.M. CRAPO. 2001. The treatment of subclinical hypothyroidism is seldom necessary. J. Clin. Endocrinol. Metab. 86: 4591-4599.